Search

Astellas Pharma Inc. US
  • Top MenuAbout
    U.S. Corporate Profile
    Learn more about Astellas U.S.
    Read More
    • Company Facts
      • Astellas Fact Sheet
      • Integrated Report
    • Contact Us
    • Ethics & Compliance
    • Governance
    • Group Code of Conduct
    • Locations
    • Philosophy
      • Charter of Corporate Conduct
    • Policies & Position Statements
    • Political Contributions
    • Regulations
      • State Regulations
        • California Declaration of Comprehensive Compliance Program
        • Vermont’s Pharmaceutical Marketer Price Disclosure
        • Wholesale Acquisition Cost Information for Colorado Prescribers
      • Consumer Product Safety Commission Regulations
    • U.S. Corporate Profile
      • Locations
    • U.S. Leadership
      • Joe Devaney
      • Lynn Fenicchia
      • Mark Reisenauer
      • Phil Tennant
      • Lei Ding
    • U.S. Products
      • Medical Safety
        • Safety Data Sheets (v 3.0)
    • Vision & Strategy
  • Top MenuInnovation
    Clinical Trials
    This website provides access to information from Astellas sponsored clinical trials and the purpose is not to promote or advertise any...
    Read More
    • Partnering
      • Track Record
      • Areas of Interest
      • Partnering Inquiry
    • R&D
      • Approach
      • Clinical Trials
      • Ethics & Principles
      • Pipeline
  • Top MenuSUSTAINABILITY
    Changing Tomorrow Day
    Read about our annual day of service.
    Read More
    • Access Accelerated
    • Changing Tomorrow Day
    • Corporate Grants
    • COVID-19 Community Response
    • Employee Impact
  • Top MenuNews
    Annual Report
    Read about our latest progress around our Corporate Strategic Plan.
    Read More
    • Annual Report
    • Articles
    • Media Inquiries
    • News Releases
      • Stories
      • Corporate
      • Corporate Awards
      • Corporate Social Responsibility
      • Our People
      • Therapeutic Area News
    • Statements
    • Video Gallery

Stakeholders menu

  • COVID-19 Response
  • Patient Focus
    • Support for Patients
      • Astellas Pharma Support Solutions
    • Issues that Matter to You
    • Patient Centricity
    • Patient Partnerships
    • U.S. Products
  • Careers
  • Partnering
  • Contact Us

Common header menu

  • IMPORTANT NOTICE
  • WORLDWIDE
  • US
  • WORLDWIDE - US
Important Notice

This website is intended for U.S. residents only. This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including those under development. Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.

Close
Previous Pause Next
Astellas Named a Best Workplace in BioPharma Astellas Named a Best Workplace in BioPharma Read More
U.S. FDA Accepts Astellas' New Drug Application for Fezolinetant U.S. FDA Accepts Astellas' New Drug Application for Fezolinetant Read More
Astellas Consistently Recognized as a Top Company for Working Parents Astellas Consistently Recognized as a Top Company for Working Parents Read More
Astellas Oncology Announces Grand Prize Winner in Annual C3 Prize to Cultivate Innovation in Cancer Care Beyond Medicine Astellas Oncology Announces Grand Prize Winner in Annual C3 Prize to Cultivate Innovation in Cancer Care Beyond Medicine Read More
Learn more about our clinical trials and educational resources on the clinical trial process. Learn more about our clinical trials and educational resources on the clinical trial process. Read More
Meet Our 2022 Working Parents of the Year Meet Our 2022 Working Parents of the Year Read More
Promoting Patient Access in the States – Video Discussion featuring Astellas US President Mark Reisenauer Promoting Patient Access in the States – Video Discussion featuring Astellas US President Mark Reisenauer Read More
Astellas is Named a Best Workplace in Chicago by Great Place to Work and Fortune Magazine Astellas is Named a Best Workplace in Chicago by Great Place to Work and Fortune Magazine Read More
1
2
3
4
5
6
7
8

News

Press Releases

U.S.A.
News / Press Releases
Mar 22, 2023
Astellas Announces Positive Findings from Phase 3 GLOW Trial of Zolbetuximab during March ASCO Plenary Series
Read More
U.S.A.
News / Press Releases
Mar 17, 2023
Phase 3 Study Shows XTANDI® (enzalutamide) plus Leuprolide Significantly Improves Metastasis-Free Survival in Men with Non-Metastatic Prostate Cancer
Read More
U.S.A.
News / Press Releases
Mar 14, 2023
Results from Astellas' Pivotal Phase 3 SKYLIGHT 1™ Study of Fezolinetant for Vasomotor Symptoms Due to Menopause Published in The Lancet
Read More

All Global Press Releases >

View US Newsroom
Patient Focus

Learn more about our commitment to patients and available resources

Read More
Investors

Access financial information, investor relations library, analyst coverage and more

Read More
Contact Us

Call us at (800) 888-7704, M-F, 8AM-7PM CT

Read More
Astellas LogoAstellas Changing Tomorrow

Follow us on social media

Facebook icon Linkedin icon Twitter icon

Bottom footer menu

  • SITE MAP
  • PRIVACY POLICY
  • COOKIES POLICY
  • ACCESSIBILITY
  • LEGAL DISCLAIMER
  • CONTACT US
© 2023 Astellas Pharma US, Inc.

Update Cookies Preferences